TEVA icon

Teva Pharmaceuticals
TEVA

Overview Fund Trends Analyst Outlook Journalist POV

506 hedge funds and large institutions have $11.5B invested in Teva Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 67 funds opening new positions, 131 increasing their positions, 190 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

23% less funds holding in top 10

Funds holding in top 10: 13 → 10 (-3)

31% less repeat investments, than reductions

Existing positions increased: 131 | Existing positions reduced: 190

34% less call options, than puts

Call options by funds: $401M | Put options by funds: $612M

Holders
506
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$401M
Puts
$612M
Net Calls
Net Calls Change

Top Buyers

1
+$579M
2
+$392M
3
+$370M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$308M
5
TCIM
TIAA CREF Investment Management
New York
+$66M

Top Sellers

1
-$156M
2
-$109M
3
-$85.5M
4
Millennium Management
Millennium Management
New York
-$49.4M
5
Morgan Stanley
Morgan Stanley
New York
-$44.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$65.1M
27
$59.4M
28
$57.9M
29
$57.9M
30
$51.3M
31
$50.5M
32
$48.5M
33
$48.4M
34
$47.5M
35
$46.2M
36
$42.3M
37
$37.5M
38
$36.2M
39
$35.6M
40
$35M
41
$34.2M
42
$33.2M
43
$32.9M
44
$32.7M
45
$31.9M
46
$31M
47
$29.8M
48
$27.3M
49
$27M
50
$27M
1
2
3 4 5